Viemed Healthcare Q2 2024 Adj. EPS $0.04 Misses $0.07 Estimate, Sales $55.000M Beat $53.800M Estimate
Viemed Healthcare Q2 2024 Adj. EPS $0.04 Misses $0.07 Estimate, Sales $55.000M Beat $53.800M Estimate
viemed healthcare 2024年Q2每股收益調整後爲0.04美元，低於0.07美元的預期，銷售額爲5500萬美元，超過5380萬美元的預期。
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $55.000 million which beat the analyst consensus estimate of $53.800 million by 2.23 percent. This is a 26.99 percent increase over sales of $43.311 million the same period last year.
viemed healthcare（納斯達克:VMD）每股盈利爲0.04美元，比分析師共識預期低42.86％。該公司本季度銷售額爲5500萬美元，比分析師共識預期高2.23％。這比去年同期4331.1萬美元的銷售額增長了26.99％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。